CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-21 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2021-05-17 | Donhauser Peter D.O. Director | Purchase | +1,000 | $10.93 | $11K | 2,165 |
| 2021-02-24 | FAVUS ELLIOT Director | Option exercise | +45,500 | $2.58 | $117K | 45,000 |
| 2021-02-24 | FAVUS ELLIOT Director | Option exercise | +100,000 | $3.28 | $328K | 145,000 |
| 2021-02-24 | FAVUS ELLIOT Director | Sale | −145,500 | $12.66 | $1.8M | 0 |
| 2021-02-24 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −45,500 | 0 | ||
| 2021-02-24 | FAVUS ELLIOT Director | Option exercise · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2021-02-19 | Donhauser Peter D.O. Director | Purchase | +1,000 | $12.62 | $13K | 1,000 |
| 2021-02-19 | Donhauser Peter D.O. Director | Purchase | +165 | $12.97 | $2K | 1,165 |
| 2020-12-30 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-30 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-30 | Boenisch Sandra PFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-12-30 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-30 | FAVUS ELLIOT Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-30 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-30 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2020-01-06 | Boenisch Sandra PFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2020-01-06 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-06 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-01-06 | MISSLING CHRISTOPHER U President and CEO | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 |
Page 6 of 12 · 232 trades